Clinical Trials Browser

Breast Neoplasms

Esophageal Squamous Cell Carcinoma

Colonic Neoplasms, Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Brain Neoplasms, Breast Neoplasms, Meningeal Neoplasms, Meningeal Carcinomatosis

HER2 Positive Metastatic Breast Cancer

HER2+ Breast Cancer

Biliary Tract Neoplasms

Stomach Neoplasms

Advanced Biliary Cancer

Anus Diseases, Anus Neoplasms, Carcinoma, Carcinoma, Squamous Cell, Neoplasms, Neoplasms, Squamous Cell

Rectal Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Breast Diseases, Breast Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Skin Diseases

Stomach Neoplasms

HER2 Positive Metastatic Breast Cancer

Esophageal Malignant Neoplasm, Local Recurrence

Rectal Neoplasms

Breast Neoplasms

Stomach Neoplasms

Breast Neoplasms

Patient Compliance, Colorectal Neoplasms

HER2-positive Advanced Breast Cancer

HER-2-positive Advanced Breast Cancer

Stomach Neoplasms

Nasopharyngeal Carcinoma

Digestive System Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Stomach Diseases, Stomach Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma

Rectal Neoplasms

Breast Neoplasms, Breast Neoplasms, Male

Stomach Neoplasms

Locally Advanced Colorectal Cancer

Breast Neoplasms, Genetic Predisposition to Disease

Stomach Neoplasms

Hyperthermia, Pancreatic Neoplasms

Breast Neoplasms

Neoplasms, Colorectal Neoplasms

Stomach Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms

Breast Neoplasm Female

Pancreatic Neoplasms

Colorectal Neoplasms

Gallbladder Neoplasms, Cholangiocarcinoma

Nasopharyngeal Carcinoma

Rectal Neoplasms, Colorectal Neoplasms

Nasopharyngeal Carcinoma

Clinical Trials

A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2

Escape

IDEA

C-CLASSIC

Study of Chemotherapy Combination With Autologous Cell Immunotherapy in the Recurrent and Metastatic Colorectal Cancer

CONVERT: Neoadjuvant Chemotherapy Alone Versus Preoperative Chemoradiation for Locally Advanced Rectal Cancer Patients

ANGLeD

A Study of Pyrotinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer

Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

Gemcitabine+ Capecitabine Vs Capecitabine in Curatively Resected Biliary Tract Cancer

ARMANI

A Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule as Second-line Treatment in Subjects With Advanced Biliary Cancer

Efficacy Study of Chemoradiotherapy With or Without Paclitaxel in Squamous-cell Anal Carcinoma Patients

RuCorT-01

RuCorT-02

RuCorT-03

CAMELLIA

A Clinical Trial of Two Adjuvant Chemotherapy Regimens for Postoperative Gastric Cancer

Pyrotinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer. (PHOEBE)

Clinical Control Study of Immunotherapy and Concurrent Chemoradiotherapy in Patients With Esophageal Cancer Recurrence

TESAR

FAVOR

Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer

NX in Luminal B Breast Cancer Patients After Neoadjuvant Chemotherapy

SOX Versus XELOX as Adjuvant Chemotherapy for Stage III Colorectal Cancer Patients

The Efficacy and Safety of BAT8001 Injection for the Treatment of HER2-positive Advanced Breast Cancer

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody (GB221) for Injection

Cytoreductive Surgery Combined With HIPEC and Chemotherapy for Gastric Cancer With Peritoneal Metastasis

CAN

The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric Cancer

AdBTC-1

Adjuvant Chemotherapy in Patients With Clinical Stage III Rectal Cancer Undergoing Neoadjuvant Chemoradiotherapy

TACT2

Evaluate the Efficacy of Maintenance Treatment With Capecitabine Plus Apatinib in Advanced Gastric Cancer

Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Versus no HIPEC in Locally Advanced Colorectal Cancer (APEC Study)

Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast Cancer

XELOX Plus Apatinib vs XELOX as Post-operative Chemotherapy in Locally Advanced Gastric Signet Ring Carcinoma

HEAT

Chemotherapy With or Without Bevacizumab in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer That Can Be Removed By Surgery

Adjuvant Therapy(3 vs. 6 Months) With the FOLFOX 4 or XELOX for Stage II or Stage III Colon Cancer

Phase 3 Study of Xelox Followed by Maintenance Capecitabine in the Advanced Gastric Cancer

Comparative Study on Two Post-operative Adjuvant Chemotherapy Regimens for Treating Triple-negative Breast Cancer

PERS

NACVCAC

A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients

LcACEC

Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic Cholangiocarcinoma

Induction Chemotherapy of TPX in Nomogram-predicted High Risk Locoregionally Advanced Nasopharyngeal Carcinoma

Radiation Therapy and Either Capecitabine or Fluorouracil With or Without Oxaliplatin Before Surgery in Treating Patients With Resectable Rectal Cancer

Cisplatin Plus Docetaxel Versus Cetuximab, Cisplatin, and Docetaxel in Metastatic Nasopharyngeal Carcinoma